Future research should focus on exploring targeted intervention strategies for key pathways including TLR4, PD-L1, and FABP4, aiming to protect the structural and functional integrity of LSECs and improve sepsis-related immune imbalance and organ dysfunction. This evidence concerns the gene FABP4 and Sepsis.